This page shows the latest quarterly results news and features for those working in and with pharma, biotech and healthcare.
The positive quarterly results build on BMS’ key patent challenge victory on Wednesday for its blood thinner Eliquis (apixaban). ... One concerning caveat among the otherwise positive results was the decrease in sales for BMS’ immunotherapy Opdivo,
Shares rose almost 2% in the wake of the presentation. Albert Bourla’s first quarterly results call as chief executive of Pfizer didn’t reveal any big surprises, but it demonstrated ... Albert Bourla, CEO, Pfizer. Much like Eli Lilly, Pfizer’s
Their approach is very different from big pharma as they aren't distracted by quarterly earnings calls and full year results which allows them to place quite big bets that may
Sir Andrew Witty's last results presentation as chief executive of GlaxoSmithKline was a good one, with the UK drugmaker beating analysts' expectations thanks to a good performance for HIV and
Potential immuno-oncology blockbuster durvalumab leads the charge for AZ’s new launches
Shifts focus to newer therapies in anticipation of brewing biosimilar competition
More from news
Approximately 16 fully matching, plus 11 partially matching documents found.
This is in contrast to larger public companies that need to answer to shareholders and consistently post positive quarterly results.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Established in 2001, Fishawack Health (FH) is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries....